ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 88 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.87 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,283,230 | -8.7% | 209,040 | -11.4% | 0.78% | +6.6% |
Q2 2023 | $4,689,320 | +16.0% | 236,000 | 0.0% | 0.73% | +8.3% |
Q1 2023 | $4,042,680 | -1.7% | 236,000 | +214.7% | 0.68% | +85.2% |
Q4 2020 | $4,113,000 | -21.1% | 75,000 | -67.1% | 0.36% | -28.7% |
Q3 2020 | $5,212,000 | -26.8% | 228,016 | -32.9% | 0.51% | -23.5% |
Q2 2020 | $7,117,000 | +52.3% | 340,016 | +1.5% | 0.67% | +14.6% |
Q1 2020 | $4,673,000 | -43.3% | 335,016 | -7.4% | 0.58% | -14.0% |
Q4 2019 | $8,237,000 | +7.1% | 361,888 | -45.2% | 0.68% | -42.8% |
Q3 2019 | $7,689,000 | +65.4% | 660,000 | +112.9% | 1.19% | +86.8% |
Q2 2019 | $4,650,000 | -8.6% | 310,000 | +6.9% | 0.64% | +37.1% |
Q1 2019 | $5,087,000 | +18.4% | 290,001 | 0.0% | 0.46% | -4.1% |
Q4 2018 | $4,298,000 | +534.9% | 290,001 | +741.2% | 0.48% | +420.4% |
Q2 2018 | $677,000 | -88.1% | 34,475 | -88.6% | 0.09% | -89.2% |
Q1 2018 | $5,668,000 | – | 302,275 | – | 0.86% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |